The last two decades have seen a growing trend on the request for noninvasive esthetic medicine treatments. 1 This phenomenon is probably due to a widespread social need and/or desire for beauty that has reached both sexes of nearly every age, group, and ethnicity. Inappropriately, esthetic treatments are often proposed as a "one-size-fits-all" solution. However, no treatment is effective

No abstract

Background The aesthetic appearance of the skin, with the emergence of wrinkles, blemishes, and infraorbital hollowing, can be a cause of social distress and is a process exacerbated by aging. The presence of skin imperfections and aging is partly due to a loss of hyaluronic acid (HA), which normally contributes to a maintain a healthy and voluminous skin. Attempts to restore volume and revert the signs of aging have therefore focused on the use of dermatologic fillers based on HA. Aim Here, we tested the safety and efficacy of MelHA®‐Monophasic Elastic Hyaluronic Acid (Concilium FEEL® filler products) containing HA at different concentrations and injected at different sites according to recommendations. Methods Five different physicians assessed 42 patients across five different medical facilities in Italy, where they performed the treatment and assessed the patients after a follow‐up visit. Safety and efficacy of the treatment and change in quality of life after treatment were evaluated with two surveys, one directed to medical personnel, and one directed to patients. Results Our results show that, across all products and personalized treatments, patients', physicians' and “independent photography reviewer” satisfaction was very high and that the treatment show a favorable safety profile. Conclusion These results are promising and suggest the use of Concilium Feel® filler products can contribute to an increased self‐esteem and quality of life in aging patients.